In this section we present key documents and evidence in relation to the health reform programme in Ireland.
Ireland’s share of older people is expected to increase significantly in the next decade. The cost of claims in the private health insurance market is rising steeply for the over 80 age group in particular.
In July 2016, the Government and the Irish Pharmaceutical Healthcare Association agreed new conditions for the supply of medicines to the Irish Health Service. The new deal covers the period to 31 August, 2020 and may lead to savings of about €600 million over the next 4 years
Analysis of expenditure and outputs in the Irish health system compared to other OECD countries.
A look at the relationship between absenteeism and agency/overtime costs in the forty largest acute hospitals in Ireland and the potential cost savings by bringing absenteeism in line with the HSE target of 3.5%.
Analysis of the efficiency of Irish hospitals by comparing average length of stay in Ireland to other countries in the OECD.
A look at the hugely significant “Future Health” framework issued by the Department of Health and Children in 2012. If acted upon, it will affect our well-being and economic and social performance unlike any other initiative. If we get it wrong, it will cause huge damage. If we get it right, it could be transformative in a positive sense.